Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 30 entries
Sorted by: Best Match Show Resources per page
Toxicogenetics and nutrigenetics: biomarkers in occupational medicine and litigation.

Biomarkers in medicine

McGinty SA.
PMID: 20477374
Biomark Med. 2007 Dec;1(4):567-73. doi: 10.2217/17520363.1.4.567.

Along with other 'omic' technologies, advances in nutritional genomics are likely to lead to increasing personalization in the area of nutrition, diet and health. The power of nutrients to modulate the toxicity of environmental pollutants and the importance of...

Cite
McGinty SA. Toxicogenetics and nutrigenetics: biomarkers in occupational medicine and litigation. Biomark Med. 2007;1(4):567-73doi: 10.2217/17520363.1.4.567.
McGinty, S. A. (2007). Toxicogenetics and nutrigenetics: biomarkers in occupational medicine and litigation. Biomarkers in medicine, 1(4), 567-73. https://doi.org/10.2217/17520363.1.4.567
McGinty, Susan A. "Toxicogenetics and nutrigenetics: biomarkers in occupational medicine and litigation." Biomarkers in medicine vol. 1,4 (2007): 567-73. doi: https://doi.org/10.2217/17520363.1.4.567
McGinty SA. Toxicogenetics and nutrigenetics: biomarkers in occupational medicine and litigation. Biomark Med. 2007 Dec;1(4):567-73. doi: 10.2217/17520363.1.4.567. PMID: 20477374.
Copy Download .nbib Format: NLM
Vox Sanguinis International Forum on the use of prehospital blood products and pharmaceuticals in the treatment of patients with traumatic hemorrhage.

Vox sanguinis

Yazer MH, Spinella PC, Allard S, Roxby D, So-Osman C, Lozano M, Gunn K, Shih AW, Stensballe J, Johansson PI, Bagge Hansen M, Maegele M, Doughty H, Crombie N, Jenkins DH, McGinity AC, Schaefer RM, Martinaud C, Shinar E, Strugo R, Chen J, Russcher H.
PMID: 30345514
Vox Sang. 2018 Nov;113(8):816-830. doi: 10.1111/vox.12677. Epub 2018 Oct 21.

No abstract available.

Cite
Yazer MH, Spinella PC, Allard S, et al. Vox Sanguinis International Forum on the use of prehospital blood products and pharmaceuticals in the treatment of patients with traumatic hemorrhage. Vox Sang. 2018;113(8):816-830doi: 10.1111/vox.12677.
Yazer, M. H., Spinella, P. C., Allard, S., Roxby, D., So-Osman, C., Lozano, M., Gunn, K., Shih, A. W., Stensballe, J., Johansson, P. I., Bagge Hansen, M., Maegele, M., Doughty, H., Crombie, N., Jenkins, D. H., McGinity, A. C., Schaefer, R. M., Martinaud, C., Shinar, E., Strugo, R., Chen, J., & Russcher, H. (2018). Vox Sanguinis International Forum on the use of prehospital blood products and pharmaceuticals in the treatment of patients with traumatic hemorrhage. Vox sanguinis, 113(8), 816-830. https://doi.org/10.1111/vox.12677
Yazer, M H, et al. "Vox Sanguinis International Forum on the use of prehospital blood products and pharmaceuticals in the treatment of patients with traumatic hemorrhage." Vox sanguinis vol. 113,8 (2018): 816-830. doi: https://doi.org/10.1111/vox.12677
Yazer MH, Spinella PC, Allard S, Roxby D, So-Osman C, Lozano M, Gunn K, Shih AW, Stensballe J, Johansson PI, Bagge Hansen M, Maegele M, Doughty H, Crombie N, Jenkins DH, McGinity AC, Schaefer RM, Martinaud C, Shinar E, Strugo R, Chen J, Russcher H. Vox Sanguinis International Forum on the use of prehospital blood products and pharmaceuticals in the treatment of patients with traumatic hemorrhage. Vox Sang. 2018 Nov;113(8):816-830. doi: 10.1111/vox.12677. Epub 2018 Oct 21. PMID: 30345514.
Copy Download .nbib Format: NLM
Biomimetic Nanotherapies: Red Blood Cell Based Core-Shell Structured Nanocomplexes for Atherosclerosis Management.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Wang Y, Zhang K, Qin X, Li T, Qiu J, Yin T, Huang J, McGinty S, Pontrelli G, Ren J, Wang Q, Wu W, Wang G.
PMID: 31380165
Adv Sci (Weinh). 2019 Apr 24;6(12):1900172. doi: 10.1002/advs.201900172. eCollection 2019 Jun 19.

Cardiovascular disease is the leading cause of mortality worldwide. Atherosclerosis, one of the most common forms of the disease, is characterized by a gradual formation of atherosclerotic plaque, hardening, and narrowing of the arteries. Nanomaterials can serve as powerful...

Cite
Wang Y, Zhang K, Qin X, et al. Biomimetic Nanotherapies: Red Blood Cell Based Core-Shell Structured Nanocomplexes for Atherosclerosis Management. Adv Sci (Weinh). 2019;6(12):1900172doi: 10.1002/advs.201900172.
Wang, Y., Zhang, K., Qin, X., Li, T., Qiu, J., Yin, T., Huang, J., McGinty, S., Pontrelli, G., Ren, J., Wang, Q., Wu, W., & Wang, G. (2019). Biomimetic Nanotherapies: Red Blood Cell Based Core-Shell Structured Nanocomplexes for Atherosclerosis Management. Advanced science (Weinheim, Baden-Wurttemberg, Germany), 6(12), 1900172. https://doi.org/10.1002/advs.201900172
Wang, Yi, et al. "Biomimetic Nanotherapies: Red Blood Cell Based Core-Shell Structured Nanocomplexes for Atherosclerosis Management." Advanced science (Weinheim, Baden-Wurttemberg, Germany) vol. 6,12 (2019): 1900172. doi: https://doi.org/10.1002/advs.201900172
Wang Y, Zhang K, Qin X, Li T, Qiu J, Yin T, Huang J, McGinty S, Pontrelli G, Ren J, Wang Q, Wu W, Wang G. Biomimetic Nanotherapies: Red Blood Cell Based Core-Shell Structured Nanocomplexes for Atherosclerosis Management. Adv Sci (Weinh). 2019 Apr 24;6(12):1900172. doi: 10.1002/advs.201900172. eCollection 2019 Jun 19. PMID: 31380165; PMCID: PMC6662054.
Copy Download .nbib Format: NLM
Surface Area of Decompressive Craniectomy Predicts Bone Flap Failure after Autologous Cranioplasty: A Radiographic Cohort Study.

Neurotrauma reports

Johnson WC, Ravindra VM, Fielder T, Ishaque M, Patterson TT, McGinity MJ, Lacci JV, Grandhi R.
PMID: 34901938
Neurotrauma Rep. 2021 Aug 27;2(1):391-398. doi: 10.1089/neur.2021.0015. eCollection 2021.

Skull bone graft failure is a potential complication of autologous cranioplasty after decompressive craniectomy (DC). Our objective was to investigate the association of graft size with subsequent bone graft failure after autologous cranioplasty. This single-center retrospective cohort study included...

Cite
Johnson WC, Ravindra VM, Fielder T, et al. Surface Area of Decompressive Craniectomy Predicts Bone Flap Failure after Autologous Cranioplasty: A Radiographic Cohort Study. Neurotrauma Rep. 2021;2(1):391-398doi: 10.1089/neur.2021.0015.
Johnson, W. C., Ravindra, V. M., Fielder, T., Ishaque, M., Patterson, T. T., McGinity, M. J., Lacci, J. V., & Grandhi, R. (2021). Surface Area of Decompressive Craniectomy Predicts Bone Flap Failure after Autologous Cranioplasty: A Radiographic Cohort Study. Neurotrauma reports, 2(1), 391-398. https://doi.org/10.1089/neur.2021.0015
Johnson, W Chase, et al. "Surface Area of Decompressive Craniectomy Predicts Bone Flap Failure after Autologous Cranioplasty: A Radiographic Cohort Study." Neurotrauma reports vol. 2,1 (2021): 391-398. doi: https://doi.org/10.1089/neur.2021.0015
Johnson WC, Ravindra VM, Fielder T, Ishaque M, Patterson TT, McGinity MJ, Lacci JV, Grandhi R. Surface Area of Decompressive Craniectomy Predicts Bone Flap Failure after Autologous Cranioplasty: A Radiographic Cohort Study. Neurotrauma Rep. 2021 Aug 27;2(1):391-398. doi: 10.1089/neur.2021.0015. eCollection 2021. PMID: 34901938; PMCID: PMC8655795.
Copy Download .nbib Format: NLM
Drug diffusion and release from a bioerodible spherical capsule.

International journal of pharmaceutics

Jain A, Mcginty S, Pontrelli G.
PMID: 34990743
Int J Pharm. 2022 Jan 03;121442. doi: 10.1016/j.ijpharm.2021.121442. Epub 2022 Jan 03.

Controlled release of a drug contained in a spherical polymer capsule is of significant interest in many fields of medicine. There is growing interest in tailoring the erosion properties of the drug to help control and optimize the drug...

Cite
Jain A, Mcginty S, Pontrelli G. Drug diffusion and release from a bioerodible spherical capsule. Int J Pharm. 2022;121442doi: 10.1016/j.ijpharm.2021.121442.
Jain, A., Mcginty, S., & Pontrelli, G. (2022). Drug diffusion and release from a bioerodible spherical capsule. International journal of pharmaceutics, 121442. https://doi.org/10.1016/j.ijpharm.2021.121442
Jain, Ankur, et al. "Drug diffusion and release from a bioerodible spherical capsule." International journal of pharmaceutics vol. (2022): 121442. doi: https://doi.org/10.1016/j.ijpharm.2021.121442
Jain A, Mcginty S, Pontrelli G. Drug diffusion and release from a bioerodible spherical capsule. Int J Pharm. 2022 Jan 03;121442. doi: 10.1016/j.ijpharm.2021.121442. Epub 2022 Jan 03. PMID: 34990743.
Copy Download .nbib Format: NLM
Mathematical modelling of fluid flow and solute transport to define operating parameters for .

Interface focus

Hyndman L, McKee S, Mottram NJ, Singh B, Webb SD, McGinty S.
PMID: 32194930
Interface Focus. 2020 Apr 06;10(2):20190045. doi: 10.1098/rsfs.2019.0045. Epub 2020 Feb 14.

In recent years, there has been a move away from the use of static

Cite
Hyndman L, McKee S, Mottram NJ, et al. Mathematical modelling of fluid flow and solute transport to define operating parameters for . Interface Focus. 2020;10(2):20190045doi: 10.1098/rsfs.2019.0045.
Hyndman, L., McKee, S., Mottram, N. J., Singh, B., Webb, S. D., & McGinty, S. (2020). Mathematical modelling of fluid flow and solute transport to define operating parameters for . Interface focus, 10(2), 20190045. https://doi.org/10.1098/rsfs.2019.0045
Hyndman, Lauren, et al. "Mathematical modelling of fluid flow and solute transport to define operating parameters for ." Interface focus vol. 10,2 (2020): 20190045. doi: https://doi.org/10.1098/rsfs.2019.0045
Hyndman L, McKee S, Mottram NJ, Singh B, Webb SD, McGinty S. Mathematical modelling of fluid flow and solute transport to define operating parameters for . Interface Focus. 2020 Apr 06;10(2):20190045. doi: 10.1098/rsfs.2019.0045. Epub 2020 Feb 14. PMID: 32194930; PMCID: PMC7061945.
Copy Download .nbib Format: NLM
Intracerebral fibroma: a case report and review of the literature.

Journal of surgical case reports

Griffith SE, McGinity MJ, Henry JM, Vecil G.
PMID: 27194681
J Surg Case Rep. 2016 May 18;2016(5). doi: 10.1093/jscr/rjw078.

Intracerebral fibromas are among the most rare neoplasms found in the central nervous system. Ten previously reported cases have been documented in the literature including only two reported cases since 1985. As a result, little is known about these...

Cite
Griffith SE, McGinity MJ, Henry JM, et al. Intracerebral fibroma: a case report and review of the literature. J Surg Case Rep. 2016;2016(5)doi: 10.1093/jscr/rjw078.
Griffith, S. E., McGinity, M. J., Henry, J. M., & Vecil, G. (2016). Intracerebral fibroma: a case report and review of the literature. Journal of surgical case reports, 2016(5), . https://doi.org/10.1093/jscr/rjw078
Griffith, Stephen E, et al. "Intracerebral fibroma: a case report and review of the literature." Journal of surgical case reports vol. 2016,5 (2016). doi: https://doi.org/10.1093/jscr/rjw078
Griffith SE, McGinity MJ, Henry JM, Vecil G. Intracerebral fibroma: a case report and review of the literature. J Surg Case Rep. 2016 May 18;2016(5). doi: 10.1093/jscr/rjw078. PMID: 27194681; PMCID: PMC4871449.
Copy Download .nbib Format: NLM
Properties of theophylline tablets dry powder coated with Eudragit((R)) E PO and Eudragit((R)) L 100-55.

Pharmaceutical development and technology

Sauer D, McGinity J.
PMID: 19552552
Pharm Dev Technol. 2009 Apr 21; doi: 10.1080/10837450902882369. Epub 2009 Apr 21.

The aim of the present study was to investigate the influence of Eudragit((R)) E PO on the drug release mechanism of Eudragit((R)) L 100-55 film coatings applied to theophylline tablets by a dry powder coating technique. The process was...

Cite
Sauer D, McGinity J. Properties of theophylline tablets dry powder coated with Eudragit((R)) E PO and Eudragit((R)) L 100-55. Pharm Dev Technol. 2009;doi: 10.1080/10837450902882369.
Sauer, D., & McGinity, J. (2009). Properties of theophylline tablets dry powder coated with Eudragit((R)) E PO and Eudragit((R)) L 100-55. Pharmaceutical development and technology, . https://doi.org/10.1080/10837450902882369
Sauer, Dorothea, and McGinity, James. "Properties of theophylline tablets dry powder coated with Eudragit((R)) E PO and Eudragit((R)) L 100-55." Pharmaceutical development and technology vol. (2009). doi: https://doi.org/10.1080/10837450902882369
Sauer D, McGinity J. Properties of theophylline tablets dry powder coated with Eudragit((R)) E PO and Eudragit((R)) L 100-55. Pharm Dev Technol. 2009 Apr 21; doi: 10.1080/10837450902882369. Epub 2009 Apr 21. PMID: 19552552.
Copy Download .nbib Format: NLM
Operation of an optical in-well-pumped vertical-external-cavity surface-emitting laser.

Applied optics

Zhang W, Ackemann T, McGinily S, Schmid M, Riis E, Ferguson AI.
PMID: 17068611
Appl Opt. 2006 Oct 10;45(29):7729-35. doi: 10.1364/ao.45.007729.

We report the operation of an optical in-well-pumped vertical-external-cavity surface-emitting laser. The laser delivers 1 W at 855 nm and is pumped with a cost-effective fiber-coupled laser diode emitting at 806 nm. The laser modal gain is examined and...

Cite
Zhang W, Ackemann T, McGinily S, et al. Operation of an optical in-well-pumped vertical-external-cavity surface-emitting laser. Appl Opt. 2006;45(29):7729-35doi: 10.1364/ao.45.007729.
Zhang, W., Ackemann, T., McGinily, S., Schmid, M., Riis, E., & Ferguson, A. I. (2006). Operation of an optical in-well-pumped vertical-external-cavity surface-emitting laser. Applied optics, 45(29), 7729-35. https://doi.org/10.1364/ao.45.007729
Zhang, Wei, et al. "Operation of an optical in-well-pumped vertical-external-cavity surface-emitting laser." Applied optics vol. 45,29 (2006): 7729-35. doi: https://doi.org/10.1364/ao.45.007729
Zhang W, Ackemann T, McGinily S, Schmid M, Riis E, Ferguson AI. Operation of an optical in-well-pumped vertical-external-cavity surface-emitting laser. Appl Opt. 2006 Oct 10;45(29):7729-35. doi: 10.1364/ao.45.007729. PMID: 17068611.
Copy Download .nbib Format: NLM
Maternal vitamin D status in Type 1 diabetic pregnancy: Impact on neonatal vitamin D status and association with maternal glycaemic control.

Pregnancy hypertension

Bennett SE, McPeake J, McCance DR, Manderson JG, Johnston P, McGalliard R, McGinty A.
PMID: 26104623
Pregnancy Hypertens. 2014 Jul;4(3):235-6. doi: 10.1016/j.preghy.2014.03.020. Epub 2014 Jul 09.

OBJECTIVE: 1. To examine relationships between 25-hydroxy vitamin D (25OHD) in women with type 1 diabetes (T1DM) during pregnancy, post-delivery and in cord blood. 2. To investigate interactions between maternal body mass index (BMI) and foetal vitamin D status....

Cite
Bennett SE, McPeake J, McCance DR, et al. Maternal vitamin D status in Type 1 diabetic pregnancy: Impact on neonatal vitamin D status and association with maternal glycaemic control. Pregnancy Hypertens. 2014;4(3):235-6doi: 10.1016/j.preghy.2014.03.020.
Bennett, S. E., McPeake, J., McCance, D. R., Manderson, J. G., Johnston, P., McGalliard, R., & McGinty, A. (2014). Maternal vitamin D status in Type 1 diabetic pregnancy: Impact on neonatal vitamin D status and association with maternal glycaemic control. Pregnancy hypertension, 4(3), 235-6. https://doi.org/10.1016/j.preghy.2014.03.020
Bennett, S E, et al. "Maternal vitamin D status in Type 1 diabetic pregnancy: Impact on neonatal vitamin D status and association with maternal glycaemic control." Pregnancy hypertension vol. 4,3 (2014): 235-6. doi: https://doi.org/10.1016/j.preghy.2014.03.020
Bennett SE, McPeake J, McCance DR, Manderson JG, Johnston P, McGalliard R, McGinty A. Maternal vitamin D status in Type 1 diabetic pregnancy: Impact on neonatal vitamin D status and association with maternal glycaemic control. Pregnancy Hypertens. 2014 Jul;4(3):235-6. doi: 10.1016/j.preghy.2014.03.020. Epub 2014 Jul 09. PMID: 26104623.
Copy Download .nbib Format: NLM
Nitric Oxide in Macrophage Immunometabolism: Hiding in Plain Sight.

Metabolites

Palmieri EM, McGinity C, Wink DA, McVicar DW.
PMID: 33114647
Metabolites. 2020 Oct 26;10(11). doi: 10.3390/metabo10110429.

Nitric Oxide (NO) is a soluble endogenous gas with various biological functions like signaling, and working as an effector molecule or metabolic regulator. In response to inflammatory signals, immune myeloid cells, like macrophages, increase production of cytokines and NO,...

Cite
Palmieri EM, McGinity C, Wink DA, et al. Nitric Oxide in Macrophage Immunometabolism: Hiding in Plain Sight. Metabolites. 2020;10(11)doi: 10.3390/metabo10110429.
Palmieri, E. M., McGinity, C., Wink, D. A., & McVicar, D. W. (2020). Nitric Oxide in Macrophage Immunometabolism: Hiding in Plain Sight. Metabolites, 10(11), . https://doi.org/10.3390/metabo10110429
Palmieri, Erika M, et al. "Nitric Oxide in Macrophage Immunometabolism: Hiding in Plain Sight." Metabolites vol. 10,11 (2020). doi: https://doi.org/10.3390/metabo10110429
Palmieri EM, McGinity C, Wink DA, McVicar DW. Nitric Oxide in Macrophage Immunometabolism: Hiding in Plain Sight. Metabolites. 2020 Oct 26;10(11). doi: 10.3390/metabo10110429. PMID: 33114647; PMCID: PMC7693038.
Copy Download .nbib Format: NLM
Cost Effectiveness of Cognitive Behavioral Therapy for the Treatment of Subjective Tinnitus in Australia.

Ear and hearing

Patel N, Malicka AN, McGinnity S, Anderson RB, Paolini AG, Crosland P.
PMID: 34456302
Ear Hear. 2021 Aug 25; doi: 10.1097/AUD.0000000000001112. Epub 2021 Aug 25.

OBJECTIVES: The aim of this study was to conduct an economic evaluation for the treatment of subjective tinnitus using different modalities of cognitive behavioral therapy (CBT) in Australia.DESIGN: A decision tree model was used to conduct a cost-utility analysis...

Cite
Patel N, Malicka AN, McGinnity S, et al. Cost Effectiveness of Cognitive Behavioral Therapy for the Treatment of Subjective Tinnitus in Australia. Ear Hear. 2021;doi: 10.1097/AUD.0000000000001112.
Patel, N., Malicka, A. N., McGinnity, S., Anderson, R. B., Paolini, A. G., & Crosland, P. (2021). Cost Effectiveness of Cognitive Behavioral Therapy for the Treatment of Subjective Tinnitus in Australia. Ear and hearing, . https://doi.org/10.1097/AUD.0000000000001112
Patel, Niraj, et al. "Cost Effectiveness of Cognitive Behavioral Therapy for the Treatment of Subjective Tinnitus in Australia." Ear and hearing vol. (2021). doi: https://doi.org/10.1097/AUD.0000000000001112
Patel N, Malicka AN, McGinnity S, Anderson RB, Paolini AG, Crosland P. Cost Effectiveness of Cognitive Behavioral Therapy for the Treatment of Subjective Tinnitus in Australia. Ear Hear. 2021 Aug 25; doi: 10.1097/AUD.0000000000001112. Epub 2021 Aug 25. PMID: 34456302.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 30 entries